drugset / Trial / NCT07073417

A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH)

NCT07073417

Phase 2 Active not recruiting 163 enrolled Hangzhou Sciwind Biosciences Co., Ltd.
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of the study is to compare the efficacy and safety of XW003 injection versus semaglutide injection in Chinese adults with obesity

Timeline

Start
2025-07-28
Primary completion
2027-02-27
Completion
2027-08-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Ecnoglutide Protein / enzyme biologic Subcutaneous
Comparator Semaglutide Peptide Subcutaneous

Indications